Why the study?
Does pretreatment with 1 mg of ibutilide improve conversion to sinus rhythm in patients undergoing transthoracic cardioversion for atrial fibrillation?
Population
100 patients with atrial fibrillation for a mean of 117+/-201 days
Comparison
Pretreatment with 1 mg of ibutilide prior to… vs Transthoracic cardioversion without ibutilide…
Design
RCT, randomly assigned
Follow-up
six months
Authors
Loading...
Supports ibutilide pretreatment before AF cardioversion; extends evidence for adjunctive facilitation of electrical restoration in randomized settings.
Does pretreatment with 1 mg of ibutilide improve conversion to sinus rhythm in patients undergoing transthoracic cardioversion for atrial fibrillation?
Pretreatment with 1 mg of ibutilide significantly enhances the success rate of transthoracic cardioversion for atrial fibrillation and reduces the energy required, though it carries a risk of polymorphic VT in patients with very low ejection fractions.
Oral et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: